November 16, 2022
Response to Tuberculosis Treatment Trials Results Published and Presented During the 2022 Union World Conference on Lung Health
Statement / Press
Treatment Action Group (TAG) and the Global Tuberculosis Community Advisory Board (TB CAB) welcome the clinical trials results recently published and presented during the 2022 Union World Conference on Lung Health, which evaluated shorter regimens and treatment shortening strategies for drug-sensitive and drug-resistant tuberculosis.
November 16, 2022
Research Toward a Cure Trials
A listing of clinical trials and observational studies related to the research effort to cure HIV infection, mainly derived from the clinicaltrials.gov online registry. Click the trial registry identifier numbers for a link to the full entry containing detailed information on the trial design, enrollment criteria, principal investigators and location(s).
November 11, 2022
1/4/6×24 Community Campaign Training Materials
Publication
Community engagement and mobilization will be key to winning equitable access to the short-course treatment and prevention regimens at the heart of the 1/4/6×24 Campaign. For everyone to benefit from the scientific progress that made these effective new preventive treatments and cures possible, governments and other duty bearers and stakeholders…
November 10, 2022
Public Comment Submitted to the Advisory Committee on Blood and Tissue Safety and Availability (ACBTSA)
Letter / Comment
Comment submitted prior to their meeting on November 17, 2022. Comment is in regard to discussion and voting on recommendation related to implementation of the HIV Organ Policy Equity (HOPE) Act of 2013, specifically pertaining to HIV-positive to HIV-positive organ transplantation and pertaining to the following draft recommendation under consideration…
November 3, 2022
TAGline November 2022
TAGline
This year’s edition of TAGline commemorates TAG’s 30th anniversary, and these articles explore TAG’s work over the years: what we’ve accomplished, what we’ve learned, the continuing obstacles to progress, and what comes next.
October 27, 2022
Community Mobilization to Ensure Health Systems’ Readiness for Long-Acting Therapies
Webinar / Presentation
On November 16, 2022, please join TAG, INPUD and AfroCAB for our webinar “Community Mobilization to Ensure Health Systems’ Readiness for Long-Acting Therapies” at 8:00 a.m. EST / 02:00 p.m. CET / 05:30 IST.
October 27, 2022
Public Health Leaders, Researchers, and Activists Launch Global Campaign to Revolutionize Tuberculosis Prevention and Treatmnt with New, Shorter, Stronger, Safer, Evidence-Based Regimens
Statement / Press
As public health leaders, researchers, and civil society activists acting in solidarity with communities affected by tuberculosis (TB), we are dismayed by the continued global backslide in progress against history’s oldest pandemic.
October 26, 2022
1 / 4 / 6 x 24
Inspired by the legacy of Dr. Paul Farmer, the 1 / 4 / 6 x 24 Campaign calls for the “staff, stuff, space, systems and support” necessary to make groundbreaking short-course TB prevention and treatment regimens accessible to all who need them as a human right by the end of…
October 24, 2022
Storytelling to Support TB Preventive Treatment (TPT)
Publication
Storytelling is a tool that can help build understanding, support discussions between members of affected communities and other stakeholders, and aid in the identification of important issues and potential solutions. The storyboards on this page describe the experiences of people who took TB preventive treatment (TPT). Daud Yamikani of Malawi…
October 20, 2022
Treatment Action Group Resource on the Demographics of Participation in HIV Cure-Related Clinical Research
In 2014, TAG began tracking HIV cure-related trials and observational studies and making the information available as a listing on our website. The primary sources are online study registries, particularly the US-based clinicaltrials.gov.
October 19, 2022
Towards Pandemic Equity: Lessons from 30 Years of Syndemic Activism
TAGline
By Mike Frick and Mark Harrington The articles in this 30th anniversary issue of TAGline grapple with “pandemic equity,” an increasingly common catchphrase in global health. COVID-19 has shown that “equity,” like its cousins “justice,” “fairness,” and “equality,” is one of those words whose use rises in proportion to its…
October 6, 2022
Treatment Action Group Statement: U.S. District Court Ruling Allowing Employers to Deny PrEP Coverage Is a Dangerous Attack on Public Health
Statement / Press
Treatment Action Group (TAG) unequivocally condemns the September 2022 U.S. District Court ruling in Fort Worth, Texas on the case Braidwood Management Inc. et al., v. Xavier Becerra et al., which ruled that the Affordable Care Act’s requirement that employers cover pre-exposure prophylaxis (PrEP) for HIV prevention was unconstitutional.
October 5, 2022
Digital Communications Consultant
Treatment Action Group (TAG) is seeking to engage a creative, highly motivated Digital Communications Consultant.
October 4, 2022
Chief Operating Officer
Treatment Action Group (TAG) is seeking a dynamic, seasoned, and strategic leader to become TAG’s Chief Operating Officer, supporting the organization as it continues to grow.
September 21, 2022
The LAT CAB Responds to MedinCell and Medicines Patent Pool License on a New Long-Acting Malaria Formulation
Statement / Press
As the global Long-Acting Technologies Community Advisory Board (LAT CAB) representing vast civil society networks, and people living with and affected by malaria, HIV, tuberculosis, and the hepatitis C virus (HCV) across the world, we welcome the efforts leading to the development of an investigational long-acting injectable (LAI) formulation of…
September 16, 2022
COVID-19 and Monkeypox: When Will They End?
Webinar / Presentation
With the emergence of MPV and the existing COVID-19 pandemic, there is growing concern amongst communities broadly on what the future holds. On September 29, please join Treatment Action Group, Black AIDS Institute, and the Coronavirus Prevention Network (CoVPN) with special guests Dr. Demetre Daskalakis, Justin James (Twitter: @TheKingOfReads), and…
September 16, 2022
Toward an Actionable and Rigorous United States Monkeypox Research Agenda
Letter / Comment
On September 14, 2022, a coalition of activists, researchers, and public health professionals sent the following letter to the White House MPX Coordinators, OSTP, CDC, and NIH/NIAID asking for a coordinated and adequately funded comprehensive Federal research effort to contain, control, and ultimately eliminate monkeypox in the US and around…
August 24, 2022
Pathways Forward to End HIV: How HIV Cure Research is Helping to Advance HIV Vaccine Research
Webinar / Presentation
On September 20, please join Treatment Action Group, Dr. Shelly Karuna, and Dr. Karine Dubé for a webinar on the next generation of bnAbs trial design and ethics related to ATIs in HIV vaccine and cure research.
August 23, 2022
Treatment Action Group Statement on Retirement of Dr. Anthony S. Fauci
Statement / Press
Treatment Action Group (TAG) meets with sadness the announcement by Dr. Anthony S. Fauci of his retirement as Director of the National Institute of Allergy and Infectious Diseases (NIAID), Chief of the NIAID Laboratory of Immunoregulation, and Chief Medical Advisor to President Biden, effective in December 2022.
August 23, 2022
Ten Principles for Access to Multi-disease Molecular Diagnostics: A Global Call to Action
Statement / Press
Treatment Action Group (TAG) and Médecins Sans Frontières (MSF) Access Campaign are pleased to launch the Principles for Access to Multi-disease Molecular Diagnostics.
August 23, 2022
Treatment Action Group Adds Three New Board Members
Statement / Press
As it celebrates its 30th Anniversary year, Treatment Action Group (TAG) announced the election of David Puente, Michael Montero and Ivy Kwan Arce to its Board of Directors.
August 18, 2022
Monkeypox Vaccine Equity Letter to NYS and NYC Health Commissioners Dr Bassett and Dr Vasan
Letter / Comment
An open letter from community partners, including TAG, asking for a mixed ID/SQ does strategy for monkeypox vaccination and demanding flexibility from our federal partners.
August 1, 2022
New Rifapentine Formulations at New Prices: No Excuses for Not Scaling-Up TB Preventive Treatment
Statement / Press
We, the undersigned civil society and community-based organizations, welcome the announcement by Unitaid and its partners that they have reached an agreement with Lupin Limited and Macleods Pharmaceuticals to introduce two formulations of rifapentine at competitive prices.
August 1, 2022
LAT CAB Calls on AbbVie, Licensed Generic Manufacturers of G/P, and the Medicines Patent Pool to Fulfill their Commitment to Make Generic HCV Treatment Widely Available
Statement / Press
Four years after the Medicines Patent Pool (MPP) and AbbVie came to agreement on a voluntary license authorizing MPP to sublicense G/P to generic manufacturers to ensure commercialization in low- and middle-income countries, generic G/P is not available anywhere.
July 31, 2022
1 / 4 / 6 x 24 Campaign Launched to Rally Energy, Political Will, Funding Needed to Fight Tuberculosis
Statement / Press
Against the backdrop of the COVID-19 pandemic and other concurrent global health, economic, social, and political crises, the 1 / 4 / 6 x 24 Campaign, launched during the AIDS conference in Montreal, seeks to improve TB treatment and prevention worldwide based on the latest medical innovations and to reignite…